Wealthspire Advisors (Maryland)’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-81
Closed -$6K – 747
2019
Q1
$6K Buy
81
+58
+252% +$3.89K ﹤0.01% 1725
2018
Q4
$1K Sell
23
-118
-84% -$10.2K ﹤0.01% 2240
2018
Q3
$16K Sell
141
-272
-66% -$30.7K ﹤0.01% 1384
2018
Q2
$52K Sell
413
-132
-24% -$16.1K ﹤0.01% 959
2018
Q1
$59K Sell
545
-2
-0.4% -$221 0.01% 915
2017
Q4
$60K Buy
547
+57
+12% +$5.69K 0.01% 926
2017
Q3
$48K Sell
490
-52
-10% -$5.04K 0.01% 991
2017
Q2
$55K Buy
542
+359
+196% +$38.7K 0.01% 916
2017
Q1
$21K Sell
183
-14
-7% -$1.63K ﹤0.01% 1064
2016
Q4
$24K Buy
197
+66
+50% +$7.31K ﹤0.01% 962
2016
Q3
$15K Buy
131
+20
+18% +$2.3K ﹤0.01% 1132
2016
Q2
$14K Sell
111
-143
-56% -$17.3K ﹤0.01% 1109
2016
Q1
$29K Hold
254
– – 0.01% 844
2015
Q4
$28K Buy
+254
New +$29.1K 0.01% 866

Other funds holding CLB

Wealthspire Advisors (Maryland)'s CLB Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 81 shares — an estimated $6K sold.

Wealthspire Advisors (Maryland) first reported a position in CLB in Q4 2015 and held it in 14 quarters. The position peaked at $60K in Q4 2017. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 81 Core Laboratories shares in Q2 2019, an estimated $6K.
  • Wealthspire Advisors (Maryland) first reported a position in Core Laboratories in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Core Laboratories position peaked at $60K in Q4 2017.
  • 304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.